705-P: CGM Attitudes and Adoption among People with Type 2 Diabetes Using One Drop

Background: Despite research establishing the strong benefits of continuous glucose monitors (CGMs) in the management of diabetes, adoption remains low among people with type 2 diabetes (T2D) . The present mixed-method study describes CGM attitudes and use among people with T2D. Method: Members with...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes (New York, N.Y.) N.Y.), 2022-06, Vol.71 (Supplement_1)
Hauptverfasser: SEARS, LINDSAY, IMRISEK, STEVEN D., HOY-ROSAS, JAMILLAH R., LAVAYSSE, LINDSEY M., LEE, MATTHEW, CHAPMAN, MATTHEW R., DACHIS, JEFF
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue Supplement_1
container_start_page
container_title Diabetes (New York, N.Y.)
container_volume 71
creator SEARS, LINDSAY
IMRISEK, STEVEN D.
HOY-ROSAS, JAMILLAH R.
LAVAYSSE, LINDSEY M.
LEE, MATTHEW
CHAPMAN, MATTHEW R.
DACHIS, JEFF
description Background: Despite research establishing the strong benefits of continuous glucose monitors (CGMs) in the management of diabetes, adoption remains low among people with type 2 diabetes (T2D) . The present mixed-method study describes CGM attitudes and use among people with T2D. Method: Members with T2D with a paid subscription to One Drop completed a survey about One Drop and their health. Qualitative reasons for and against CGM adoption were coded and reported with descriptive statistics. Results: Of the 171 respondents, 55% were male, 70% were White, 86% were non-Hispanic and average age was 55.4 (SD=11.7) . Approximately 92% of members reported logging their blood sugar daily or weekly, 96% of members found One Drop’s health logging features helpful, and 95% found the glucose analysis and reports helpful. Most members were familiar with CGM devices (90%) , and of that group, 83% had never tried one. Most of those familiar with CGMs were also open to CGM adoption (N=107; 79%) . Reasons for openness included valuing continuous feedback (28) , relief from fingersticks (15) , convenience (12) and improved diabetes management (12) , while a subset expressed concerns about insurance coverage and costs (12) . Those not open to CGM adoption (N=29) cited a lack of need (9) , lack of familiarity (4) , inconvenience (3) , pain/size of devices (3) and costs (2) . Conclusion: Despite their established benefit, CGM adoption among people with T2D is concerningly low. While awareness and interest in CGM adoption is high, costs are a concern, and there is a subset that would benefit from more education and exposure. Advancements in device technology, reimbursement policy as well as interventions to increase health knowledge and motivation are warranted to better meet the needs and preferences of people with T2D.
doi_str_mv 10.2337/db22-705-P
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2685589541</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2685589541</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1041-ceaf4d68d16b982c38b69a5d29aba1267bf9879f2e1b457c115b51d825ec3e713</originalsourceid><addsrcrecordid>eNot0E1LAzEQgOEgCtbqxV8Q8CZE87HZJN5KW6tQaZEWvIVkk9Ut7WZNUqT_3q2VOczlYQZeAG4JfqCMiUdnKUUCc7Q8AwOimEKMio9zMMCYUESEEpfgKqUNxrjsZwDe__ATHM_e4CjnJu-dT9C0Do5c6HITWmh2of2ESx-6rYc_Tf6Cq0PnIYWTxlife75OTS8WrYeTGLprcFGbbfI3_3sI1s_T1fgFzRez1_FojiqCC4Iqb-rCldKR0ipJKyZtqQx3VBlrCC2FrZUUqqae2IKLihBuOXGScl8xLwgbgrvT3S6G771PWW_CPrb9S01LyblUvDiq-5OqYkgp-lp3sdmZeNAE62MzfWym-wx6yX4BWLxcIQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2685589541</pqid></control><display><type>article</type><title>705-P: CGM Attitudes and Adoption among People with Type 2 Diabetes Using One Drop</title><source>PubMed Central</source><source>EZB Electronic Journals Library</source><creator>SEARS, LINDSAY ; IMRISEK, STEVEN D. ; HOY-ROSAS, JAMILLAH R. ; LAVAYSSE, LINDSEY M. ; LEE, MATTHEW ; CHAPMAN, MATTHEW R. ; DACHIS, JEFF</creator><creatorcontrib>SEARS, LINDSAY ; IMRISEK, STEVEN D. ; HOY-ROSAS, JAMILLAH R. ; LAVAYSSE, LINDSEY M. ; LEE, MATTHEW ; CHAPMAN, MATTHEW R. ; DACHIS, JEFF</creatorcontrib><description>Background: Despite research establishing the strong benefits of continuous glucose monitors (CGMs) in the management of diabetes, adoption remains low among people with type 2 diabetes (T2D) . The present mixed-method study describes CGM attitudes and use among people with T2D. Method: Members with T2D with a paid subscription to One Drop completed a survey about One Drop and their health. Qualitative reasons for and against CGM adoption were coded and reported with descriptive statistics. Results: Of the 171 respondents, 55% were male, 70% were White, 86% were non-Hispanic and average age was 55.4 (SD=11.7) . Approximately 92% of members reported logging their blood sugar daily or weekly, 96% of members found One Drop’s health logging features helpful, and 95% found the glucose analysis and reports helpful. Most members were familiar with CGM devices (90%) , and of that group, 83% had never tried one. Most of those familiar with CGMs were also open to CGM adoption (N=107; 79%) . Reasons for openness included valuing continuous feedback (28) , relief from fingersticks (15) , convenience (12) and improved diabetes management (12) , while a subset expressed concerns about insurance coverage and costs (12) . Those not open to CGM adoption (N=29) cited a lack of need (9) , lack of familiarity (4) , inconvenience (3) , pain/size of devices (3) and costs (2) . Conclusion: Despite their established benefit, CGM adoption among people with T2D is concerningly low. While awareness and interest in CGM adoption is high, costs are a concern, and there is a subset that would benefit from more education and exposure. Advancements in device technology, reimbursement policy as well as interventions to increase health knowledge and motivation are warranted to better meet the needs and preferences of people with T2D.</description><identifier>ISSN: 0012-1797</identifier><identifier>EISSN: 1939-327X</identifier><identifier>DOI: 10.2337/db22-705-P</identifier><language>eng</language><publisher>New York: American Diabetes Association</publisher><subject>Diabetes ; Diabetes mellitus (non-insulin dependent) ; Familiarity ; Glucose monitoring ; Mixed methods research ; Motivation ; Sensors ; Statistical analysis</subject><ispartof>Diabetes (New York, N.Y.), 2022-06, Vol.71 (Supplement_1)</ispartof><rights>Copyright American Diabetes Association Jun 2022</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1041-ceaf4d68d16b982c38b69a5d29aba1267bf9879f2e1b457c115b51d825ec3e713</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>SEARS, LINDSAY</creatorcontrib><creatorcontrib>IMRISEK, STEVEN D.</creatorcontrib><creatorcontrib>HOY-ROSAS, JAMILLAH R.</creatorcontrib><creatorcontrib>LAVAYSSE, LINDSEY M.</creatorcontrib><creatorcontrib>LEE, MATTHEW</creatorcontrib><creatorcontrib>CHAPMAN, MATTHEW R.</creatorcontrib><creatorcontrib>DACHIS, JEFF</creatorcontrib><title>705-P: CGM Attitudes and Adoption among People with Type 2 Diabetes Using One Drop</title><title>Diabetes (New York, N.Y.)</title><description>Background: Despite research establishing the strong benefits of continuous glucose monitors (CGMs) in the management of diabetes, adoption remains low among people with type 2 diabetes (T2D) . The present mixed-method study describes CGM attitudes and use among people with T2D. Method: Members with T2D with a paid subscription to One Drop completed a survey about One Drop and their health. Qualitative reasons for and against CGM adoption were coded and reported with descriptive statistics. Results: Of the 171 respondents, 55% were male, 70% were White, 86% were non-Hispanic and average age was 55.4 (SD=11.7) . Approximately 92% of members reported logging their blood sugar daily or weekly, 96% of members found One Drop’s health logging features helpful, and 95% found the glucose analysis and reports helpful. Most members were familiar with CGM devices (90%) , and of that group, 83% had never tried one. Most of those familiar with CGMs were also open to CGM adoption (N=107; 79%) . Reasons for openness included valuing continuous feedback (28) , relief from fingersticks (15) , convenience (12) and improved diabetes management (12) , while a subset expressed concerns about insurance coverage and costs (12) . Those not open to CGM adoption (N=29) cited a lack of need (9) , lack of familiarity (4) , inconvenience (3) , pain/size of devices (3) and costs (2) . Conclusion: Despite their established benefit, CGM adoption among people with T2D is concerningly low. While awareness and interest in CGM adoption is high, costs are a concern, and there is a subset that would benefit from more education and exposure. Advancements in device technology, reimbursement policy as well as interventions to increase health knowledge and motivation are warranted to better meet the needs and preferences of people with T2D.</description><subject>Diabetes</subject><subject>Diabetes mellitus (non-insulin dependent)</subject><subject>Familiarity</subject><subject>Glucose monitoring</subject><subject>Mixed methods research</subject><subject>Motivation</subject><subject>Sensors</subject><subject>Statistical analysis</subject><issn>0012-1797</issn><issn>1939-327X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNot0E1LAzEQgOEgCtbqxV8Q8CZE87HZJN5KW6tQaZEWvIVkk9Ut7WZNUqT_3q2VOczlYQZeAG4JfqCMiUdnKUUCc7Q8AwOimEKMio9zMMCYUESEEpfgKqUNxrjsZwDe__ATHM_e4CjnJu-dT9C0Do5c6HITWmh2of2ESx-6rYc_Tf6Cq0PnIYWTxlife75OTS8WrYeTGLprcFGbbfI3_3sI1s_T1fgFzRez1_FojiqCC4Iqb-rCldKR0ipJKyZtqQx3VBlrCC2FrZUUqqae2IKLihBuOXGScl8xLwgbgrvT3S6G771PWW_CPrb9S01LyblUvDiq-5OqYkgp-lp3sdmZeNAE62MzfWym-wx6yX4BWLxcIQ</recordid><startdate>20220601</startdate><enddate>20220601</enddate><creator>SEARS, LINDSAY</creator><creator>IMRISEK, STEVEN D.</creator><creator>HOY-ROSAS, JAMILLAH R.</creator><creator>LAVAYSSE, LINDSEY M.</creator><creator>LEE, MATTHEW</creator><creator>CHAPMAN, MATTHEW R.</creator><creator>DACHIS, JEFF</creator><general>American Diabetes Association</general><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>20220601</creationdate><title>705-P: CGM Attitudes and Adoption among People with Type 2 Diabetes Using One Drop</title><author>SEARS, LINDSAY ; IMRISEK, STEVEN D. ; HOY-ROSAS, JAMILLAH R. ; LAVAYSSE, LINDSEY M. ; LEE, MATTHEW ; CHAPMAN, MATTHEW R. ; DACHIS, JEFF</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1041-ceaf4d68d16b982c38b69a5d29aba1267bf9879f2e1b457c115b51d825ec3e713</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Diabetes</topic><topic>Diabetes mellitus (non-insulin dependent)</topic><topic>Familiarity</topic><topic>Glucose monitoring</topic><topic>Mixed methods research</topic><topic>Motivation</topic><topic>Sensors</topic><topic>Statistical analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>SEARS, LINDSAY</creatorcontrib><creatorcontrib>IMRISEK, STEVEN D.</creatorcontrib><creatorcontrib>HOY-ROSAS, JAMILLAH R.</creatorcontrib><creatorcontrib>LAVAYSSE, LINDSEY M.</creatorcontrib><creatorcontrib>LEE, MATTHEW</creatorcontrib><creatorcontrib>CHAPMAN, MATTHEW R.</creatorcontrib><creatorcontrib>DACHIS, JEFF</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><jtitle>Diabetes (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>SEARS, LINDSAY</au><au>IMRISEK, STEVEN D.</au><au>HOY-ROSAS, JAMILLAH R.</au><au>LAVAYSSE, LINDSEY M.</au><au>LEE, MATTHEW</au><au>CHAPMAN, MATTHEW R.</au><au>DACHIS, JEFF</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>705-P: CGM Attitudes and Adoption among People with Type 2 Diabetes Using One Drop</atitle><jtitle>Diabetes (New York, N.Y.)</jtitle><date>2022-06-01</date><risdate>2022</risdate><volume>71</volume><issue>Supplement_1</issue><issn>0012-1797</issn><eissn>1939-327X</eissn><abstract>Background: Despite research establishing the strong benefits of continuous glucose monitors (CGMs) in the management of diabetes, adoption remains low among people with type 2 diabetes (T2D) . The present mixed-method study describes CGM attitudes and use among people with T2D. Method: Members with T2D with a paid subscription to One Drop completed a survey about One Drop and their health. Qualitative reasons for and against CGM adoption were coded and reported with descriptive statistics. Results: Of the 171 respondents, 55% were male, 70% were White, 86% were non-Hispanic and average age was 55.4 (SD=11.7) . Approximately 92% of members reported logging their blood sugar daily or weekly, 96% of members found One Drop’s health logging features helpful, and 95% found the glucose analysis and reports helpful. Most members were familiar with CGM devices (90%) , and of that group, 83% had never tried one. Most of those familiar with CGMs were also open to CGM adoption (N=107; 79%) . Reasons for openness included valuing continuous feedback (28) , relief from fingersticks (15) , convenience (12) and improved diabetes management (12) , while a subset expressed concerns about insurance coverage and costs (12) . Those not open to CGM adoption (N=29) cited a lack of need (9) , lack of familiarity (4) , inconvenience (3) , pain/size of devices (3) and costs (2) . Conclusion: Despite their established benefit, CGM adoption among people with T2D is concerningly low. While awareness and interest in CGM adoption is high, costs are a concern, and there is a subset that would benefit from more education and exposure. Advancements in device technology, reimbursement policy as well as interventions to increase health knowledge and motivation are warranted to better meet the needs and preferences of people with T2D.</abstract><cop>New York</cop><pub>American Diabetes Association</pub><doi>10.2337/db22-705-P</doi></addata></record>
fulltext fulltext
identifier ISSN: 0012-1797
ispartof Diabetes (New York, N.Y.), 2022-06, Vol.71 (Supplement_1)
issn 0012-1797
1939-327X
language eng
recordid cdi_proquest_journals_2685589541
source PubMed Central; EZB Electronic Journals Library
subjects Diabetes
Diabetes mellitus (non-insulin dependent)
Familiarity
Glucose monitoring
Mixed methods research
Motivation
Sensors
Statistical analysis
title 705-P: CGM Attitudes and Adoption among People with Type 2 Diabetes Using One Drop
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T08%3A05%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=705-P:%20CGM%20Attitudes%20and%20Adoption%20among%20People%20with%20Type%202%20Diabetes%20Using%20One%20Drop&rft.jtitle=Diabetes%20(New%20York,%20N.Y.)&rft.au=SEARS,%20LINDSAY&rft.date=2022-06-01&rft.volume=71&rft.issue=Supplement_1&rft.issn=0012-1797&rft.eissn=1939-327X&rft_id=info:doi/10.2337/db22-705-P&rft_dat=%3Cproquest_cross%3E2685589541%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2685589541&rft_id=info:pmid/&rfr_iscdi=true